Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

March 01, 2021

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Avid Bioservices Expands Biologics Manufacturing Capacity

February 22, 2021

The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.

Wavelength Pharmaceuticals Acquires Vanamali Organics

February 18, 2021

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Cascade Chemistry Expands API Manufacturing Capacity

February 18, 2021

Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

Quotient Sciences Acquires CDMO Arcinova

February 17, 2021

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.

Avid Bioservices Enters Manufacturing Agreement with Humanigen for Lenzilumab

February 04, 2021

The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

February 04, 2021

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.

Toxicology: Ensuring Drugs are Safe for People

February 02, 2021

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

Protein Characterization Can Support Regulatory Submission

February 02, 2021

Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.